Literature DB >> 8814720

Technetium-99m tetrofosmin uptake in lung cancer: comparison with thallium-201.

I Matsunari1, S Kinuya, T Nishikawa, M Matoba, K Murakita, M Ohguchi, K Ichiyanagi, J Taki, N Tonami, K Hisada.   

Abstract

Technetium-99m tetrofosmin and thallium-201 lung SPECT imaging were performed in a patient with adenocarcinoma of the lung. Significant activities in the lung lesion were clearly depicted on both technetium-99m tetrofosmin and thallium-201 SPECT imaging. The early uptake, delayed uptake ratios and retention indices of the tumor were 2.75, 2.39 and -1.31 for thallium-201 imaging and 3.09, 2.27 and -26.5 for technetium-99m tetrofosmin imaging, respectively. This preliminary report suggests that technetium-99m tetrofosmin may have potential as a tumor imaging agent.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8814720     DOI： 10.1007/bf03165069

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN： 0914-7187            Impact factor:   2.668


  8 in total

1.  Thallium-201 single photon emission computed tomography in the evaluation of suspected lung cancer.

Authors:  N Tonami; N Shuke; K Yokoyama; H Seki; T Takayama; S Kinuya; K Nakajima; T Aburano; K Hisada; Y Watanabe
Journal:  J Nucl Med       Date:  1989-06       Impact factor: 10.057

2.  Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol.

Authors:  D Jain; F J Wackers; J Mattera; M McMahon; A J Sinusas; B L Zaret
Journal:  J Nucl Med       Date:  1993-08       Impact factor: 10.057

3.  Uptake and kinetics of Tc-99m hexakis 2-methoxy isobutyl isonitrile in benign and malignant lesions in the lungs.

Authors:  I M Hassan; A Sahweil; C Constantinides; A Mahmoud; M Nair; Y T Omar; H M Abdel-Dayem
Journal:  Clin Nucl Med       Date:  1989-05       Impact factor: 7.794

Review 4.  Tracer imaging in lung cancer.

Authors:  H M Abdel-Dayem; A Scott; H Macapinlac; S Larson
Journal:  Eur J Nucl Med       Date:  1994-01

5.  Differentiation of single solid lesions in the lungs by means of single-photon emission tomography with technetium-99m methoxyisobutylisonitrile.

Authors:  C H Kao; S J Wang; W Y Lin; C Y Hsu; S Q Liao; S H Yeh
Journal:  Eur J Nucl Med       Date:  1993-03

6.  Technetium-99m-1,2-bis[bis(2-ethoxyethyl) phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent.

Authors:  B Higley; F W Smith; T Smith; H G Gemmell; P Das Gupta; D V Gvozdanovic; D Graham; D Hinge; J Davidson; A Lahiri
Journal:  J Nucl Med       Date:  1993-01       Impact factor: 10.057

7.  Primary lung cancer SPECT imaging with pentavalent technetium-99m-DMSA.

Authors:  T Hirano; H Otake; I Yoshida; K Endo
Journal:  J Nucl Med       Date:  1995-02       Impact factor: 10.057

8.  Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging.

Authors:  J D Kelly; A M Forster; B Higley; C M Archer; F S Booker; L R Canning; K W Chiu; B Edwards; H K Gill; M McPartlin
Journal:  J Nucl Med       Date:  1993-02       Impact factor: 10.057
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.